Lisata Therapeutics
LSTA
34 hedge funds and large institutions have $7.33M invested in Lisata Therapeutics in 2021 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 7 increasing their positions, 8 reducing their positions, and 6 closing their positions.
77% more call options, than puts
Call options by funds: $521K | Put options by funds: $295K
33% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 6
6% more funds holding
Funds holding: 32 → 34 (+2)
0.11% more ownership
Funds ownership: 0.86% → 0.97% (+0.11%)
13% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 8
22% less capital invested
Capital invested by funds: $9.41M → $7.33M (-$2.08M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$672K |
| 2 |
Two Sigma Advisers
New York
|
+$244K |
| 3 |
AFM
Anson Funds Management
Dallas,
Texas
|
+$174K |
| 4 |
VF
Virtu Financial
New York
|
+$165K |
| 5 |
Two Sigma Investments
New York
|
+$165K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$240K |
| 2 |
Renaissance Technologies
New York
|
-$151K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$76.4K |
| 4 |
TSS
Two Sigma Securities
New York
|
-$33K |
| 5 |
Wolverine Trading
Chicago,
Illinois
|
-$30K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
IA
26
IFP Advisors
Tampa,
Florida
| $1K | – | – | – |
|
|
TRCT
27
Tower Research Capital (TRC)
New York
| $1K | +$1.48K | +96 | +960% |
|
|
KFS
28
Kelly Financial Services
Braintree,
Massachusetts
| $8 | – | – | – |
|
|
29
Citadel Advisors
Miami,
Florida
| – | -$76.4K | -4,947 | Closed |
|
|
TSS
30
Two Sigma Securities
New York
| – | -$33K | -1,796 | Closed |
|
|
31
Wolverine Trading
Chicago,
Illinois
| – | -$30K | -1,735 | Closed |
|
32
Barclays
London,
United Kingdom
| – | -$21.7K | -1,403 | -100% |
|
33
Qube Research & Technologies (QRT)
London,
United Kingdom
| – | -$26K | -1,403 | Closed |
|
|
GPFA
34
Game Plan Financial Advisors
Westlake,
Ohio
| – | -$21K | -1,133 | Closed |
|
35
Bank of America
Charlotte,
North Carolina
| – | -$232 | -15 | -28% |
|
|
RE
36
RBC Europe
London,
United Kingdom
| – | -$12 | -1 | Closed |
|
LSTA Hedge Fund Activity: Q4 2021 in Review
34 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Lisata Therapeutics (LSTA) for Q4 2021, worth a combined $7.33M — down 22% from $9.41M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new LSTA positions and 6 closed out — a net gain of 2 holders — while 7 added to existing stakes and 8 trimmed.
The largest buyer was Sabby Management, adding an estimated $672K. The largest seller was Susquehanna International Group, cutting an estimated $240K.
- 34 institutional investors held Lisata Therapeutics (LSTA) as of Q4 2021, up from 32 in Q3 2021.
- Funds reported $7.33M of Lisata Therapeutics stock for Q4 2021, down 22% quarter-over-quarter.
- 8 funds opened new Lisata Therapeutics positions in Q4 2021 and 6 closed out, a net change of +2 holders.
- The largest Lisata Therapeutics buyer in Q4 2021 was Sabby Management, an estimated $672K added.
- The largest Lisata Therapeutics seller in Q4 2021 was Susquehanna International Group, an estimated $240K sold.
Based on aggregated 13F filings for Q4 2021.